Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Details)

v3.20.2
Earnings Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss $ (84,130,722) $ (11,493,587) $ (210,705,940) $ (37,817,959)
Deemed dividends 0 0 0 86,207
Net loss attributable to common stockholders $ (84,130,722) $ (11,493,587) $ (210,705,940) $ (37,904,166)
Weighted average shares outstanding, basic (in shares) 107,406,000 66,176,921 83,611,526 63,566,295
Weighted average shares outstanding, diluted (in shares) 107,406,000 66,176,921 83,611,526 63,566,295
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) 5,948,219 32,917,619 5,948,219 32,917,619
Options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive effect of stock based awards (in shares) 0 0 0 0
Convertible Note, at fair value        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Dilutive effect of stock based awards (in shares) 0 0 0 0
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) 1,000,000.0   4,800,000  
Convertible Note, at fair value | Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) 6,100,000   13,300,000